Ronald Peter Erickson, Director at Kalytera Therapeutics, holds 1.20M shares in Kalytera Therapeutics (Ticker: KALTF), holds 200.00K shares in biOasis Technologies (Ticker: TSE:BTI). Most recently, Ronald Peter Erickson Bought ― shares of Kalytera Therapeutics on Sep 19, 2019 for an estimated value of 26.31K.